COVID-19, Collaboration, Liability, and Immunity

The impact of COVID-19 led competitors to collaborate to meet public needs. The Defense Production Act, the Pandemic and All-Hazards Preparedness Act, and DOJ’s Business Review Letter process offered ways for businesses to mitigate the antitrust risk of doing so and even to obtain immunity. Looking ahead, what are the implications of these COVID-19 collaborations for antitrust counselors and litigators?

On Wednesday, April 6, 2022, Morrison & Foerster partner David Shaw will moderate the “COVID-19, Collaboration, Liability, and Immunity” panel at the 70th Annual ABA Antitrust Law Spring Meeting. Presented by the Exemptions & Immunities and Joint Conduct Committees, his panel includes:

Session Chair/Moderator

David Shaw, Morrison & Foerster LLP, Washington, DC

Speakers

• Thomas O. Barnett, Covington & Burling LLP, Washington, DC
• David B. Lawrence, Chief, Competition Policy & Advocacy, U.S. Department of Justice, Antitrust Division, Washington, DC
• Margarida Matos Rosa, President, Portuguese Competition Authority, Lisbon
• June Rhee, Director, Master of Management Studies in Systemic Risk, Yale School of Management, New Haven, CT

View conference information. Continuing Legal Education Credits are being offered for this program.